These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 3388291)
41. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. Mori K; Nagasawa S J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor. Kaplan AP; Silverberg M; Dunn JT; Miller G Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951 [TBL] [Abstract][Full Text] [Related]
43. Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule. Yamamoto T Biochim Biophys Acta; 1987 Aug; 914(3):259-74. PubMed ID: 3113483 [TBL] [Abstract][Full Text] [Related]
44. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain. Page JD; You JL; Harris RB; Colman RW Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388 [TBL] [Abstract][Full Text] [Related]
45. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen. Nakayasu T; Nagasawa S J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988 [TBL] [Abstract][Full Text] [Related]
46. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens. Sugi T; McIntyre JA J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858 [TBL] [Abstract][Full Text] [Related]
47. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Silverberg M; Nicoll JE; Kaplan AP Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319 [No Abstract] [Full Text] [Related]
48. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. España F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
49. Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization. Hayashi I; Kato H; Iwanaga S; Oh-ishi S J Biol Chem; 1985 May; 260(10):6115-23. PubMed ID: 3846594 [TBL] [Abstract][Full Text] [Related]
50. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain. Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159 [TBL] [Abstract][Full Text] [Related]
51. Purification of prekallikrein from porcine plasma and its conversion to active kallikrein. Kikuno Y; Takahashi H; Suzuki T J Biochem; 1983 Jan; 93(1):235-41. PubMed ID: 6551387 [TBL] [Abstract][Full Text] [Related]
52. Role of arginine residues in the coagulant activity of high molecular weight kininogen. Chang JJ; Scott CF; Colman RW Blood; 1986 Mar; 67(3):805-10. PubMed ID: 3633200 [TBL] [Abstract][Full Text] [Related]
53. Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Bühler R; Hovinga JK; Aebi-Huber I; Furlan M; Lämmle B Blood Coagul Fibrinolysis; 1995 May; 6(3):223-32. PubMed ID: 7654936 [TBL] [Abstract][Full Text] [Related]
54. Independent consumption of high and low molecular weight kininogens in vivo. Uchida Y; Katori M Adv Exp Med Biol; 1986; 198 Pt A():113-8. PubMed ID: 3812086 [TBL] [Abstract][Full Text] [Related]
55. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077 [TBL] [Abstract][Full Text] [Related]
56. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760 [TBL] [Abstract][Full Text] [Related]
57. Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system. Müller-Esterl W; Hock H; Rauth G; Kellermann J; Lottspeich F; Henschen A Adv Exp Med Biol; 1986; 198 Pt A():97-103. PubMed ID: 3643720 [TBL] [Abstract][Full Text] [Related]
58. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization. Shimada T; Kato H; Maeda H; Iwanaga S J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613 [TBL] [Abstract][Full Text] [Related]
59. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein. Johansen HT; Briseid K Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869 [TBL] [Abstract][Full Text] [Related]
60. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit. Wiggins RC Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]